New vaginal tablet shows promise in taming recurrent bacterial vaginosis
NCT ID NCT07394777
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested the safety of using pHyph, a vaginal tablet that naturally restores acidity, for 12 days in 32 adult women with bacterial vaginosis (BV). BV is a common infection causing unpleasant discharge and odor, and often returns after antibiotic treatment. The goal was to see if a longer treatment course is safe and well-tolerated, while also checking if it helps restore healthy vaginal bacteria and relieve symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BACTERIAL VAGINOSIS (BV) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CMedical
Uppsala, Sweden
-
CTC Stockholm
Solna, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.